Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Accurate diagnosis of early stage uterine cancer requires lymph-node check

02.06.2003


Research at Washington University School of Medicine in St. Louis suggests that the accurate diagnosis of early stage endometrial cancer requires that the abdominal lymph nodes always be removed and checked for signs of cancer. The recommendation extends even to women with tumors that seem to have the smallest risk of spread. The study will be presented June 2 at the American Society of Clinical Oncology (ASCO) meeting in Chicago, Ill.



The study indicates that by examining the lymph nodes in all women with this disease, doctors can save patients from unnecessary radiation therapy, give the appropriate level of therapy to those who need it and save millions of dollars nationally.

"These findings are important," says Washington University lead investigator Thomas J. Herzog, M.D., associate professor of obstetrics and gynecology and a cancer specialist at the Siteman Cancer Center and Barnes-Jewish Hospital. "If confirmed, they will have direct clinical application and may change how many surgeons treat endometrial cancer."


Accurately determining how far cancer has progressed, a process known as staging, is essential for determining the most effective treatment for cancer patients. A tumor that has spread, or metastasized, to the lymph nodes requires stronger treatment than one that is still confined to the uterus.

"The problem is that many physicians believe early stage endometrial cancer is readily curable just by removing the uterus," says co-author Matthew A. Powell, M.D., instructor in the Division of Gynecologic Oncology. "They feel it is unnecessary to refer women to a surgical oncologist for removal and examination of the nodes."

Presently, fewer than half of women with stage 1 endometrial cancer have lymph nodes removed and checked for malignant cells. Instead, many doctors stage endometrial cancer by looking only at the tumor’s microscopic appearance and how far it has penetrated the uterine wall.

Endometrial cancer is the most common gynecological cancer in the United States, with doctors diagnosing about 40,000 cases annually. About 6,800 women die of the disease each year. About half of the women diagnosed have grade 1 endometrial cancer. The overall survival for these women is more than 90 percent.

Powell notes, however, that in 3 to 5 percent of women with grade 1 disease, the cancer has spread to the lymph nodes. Once that happens, the survival rate falls to about 60 percent.

Staging of endometrial cancer is done during surgery. Currently, an early stage tumor is treated by removal of the uterus, a procedure known as a hysterectomy. If the tumor has not spread, hysterectomy alone will usually cure the cancer. If the tumor has spread to the lymph nodes, additional therapy is needed. If the spread is minor, doctors often treat the vagina with localized radiation therapy. If the spread is broader, an external beam of radiation is used.

Often, patients are treated with radiation following surgery without checking the lymph nodes to see if the cancer has spread.

"Our findings show that if we check the lymph nodes and find no sign of cancer, we don’t need to give radiation," says Powell.

The retrospective study conducted by Herzog, Powell and colleagues looked at 144 women diagnosed with grade 1, apparent stage 1 endometrial cancer. Lymph node removal was done in 102 of these patients. The researchers looked at the records of the 102 women and determined what treatment they would have received based only on the characteristics of the tumor, as if the lymph-node examine had not been done.

They found that additional radiation therapy would have been recommended for 40 of the patients. The lymph-node exam, however, showed that only 18 of those patients actually required radiation, thereby preventing unneeded treatment in 22 patients. Another five patients would have received radiation therapy that would have been more intense than necessary. The lymph node exam also identified three women with disease that was more advanced than would have been suspected.

A cost analysis done by the researchers estimated that avoiding the unnecessary use of radiation therapy for early stage endometrial cancer could save $28 million annually in the United States.

"Based on these findings we concluded that all women with endometrial cancer, even those with minimum risk factors, should have lymph nodes examined to spare patients unnecessary treatment and reduce the cost of care," Herzog says.


Horowitz NS, Powell MA, Smith JH, Rader JS, Gibb RK, Mutch DG, Brouwer ES, Herzog TH. Staging grade 1 endometrial cancer: saving dollars and lives. American Society of Clinical Oncology annual meeting, Abstract number 1835, June 2, 2003.

The full-time and volunteer faculty of Washington University School of Medicine are the physicians and surgeons of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.

Darrell E. Ward | EurekAlert!
Further information:
http://medinfo.wustl.edu/

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>